# |
PMID |
Sentence |
1 |
18252893
|
Fibroblast growth factor 21 (FGF21) is a metabolic regulator with multiple beneficial effects on glucose homeostasis and insulin sensitivity in animal models.
|
2 |
18252893
|
Serum FGF21 correlated positively with adiposity, fasting insulin, and triglycerides but negatively with HDL cholesterol, after adjusting for age and BMI.
|
3 |
19720803
|
Fibroblast growth factor-21 (FGF-21) is a potent metabolic regulator, which in animal models has been shown to improve glucose metabolism and insulin sensitivity.
|
4 |
19720803
|
Recently, FGF-21 was shown to be expressed and secreted from murine muscle cells in response to insulin stimulation.
|
5 |
19720803
|
Furthermore, we investigated systemic levels and muscle FGF-21 expression in humans with or without insulin resistance and chronic elevated insulin.
|
6 |
19720803
|
After 3 or 4 h of insulin infusion during a hyperinsulinemic-euglycemic clamp, muscular FGF-21 expression increased significantly.
|
7 |
19720803
|
In individuals with chronic elevated insulin, muscular FGF-21 expression was associated with hyperinsulinemia in men but not in women.
|
8 |
19699495
|
Fibroblast growth factor 21 (FGF21) has beneficial effects on glucose homeostasis and insulin sensitivity.
|
9 |
20424140
|
Interestingly, a mild elevation of FFAs resulting from complete insulin deficiency also increased FGF-21 levels.
|
10 |
20424140
|
These results from two independent human RCTs suggest that FFAs increase circulating FGF-21, while insulin is only of minor importance under physiological conditions.
|
11 |
20357365
|
Despite unchanged body fat content, rats treated with intracerebroventricular FGF21 displayed a robust increase of insulin sensitivity due to increased insulin-induced suppression of both hepatic glucose production and gluconeogenic gene expression, with no change of glucose utilization.
|
12 |
19906798
|
Pharmacologic studies show that FGF21 has broad metabolic actions in obese rodents and primates that include enhancing insulin sensitivity, decreasing triglyceride concentrations, and causing weight loss.
|
13 |
21309058
|
FGF21 exposure increased basal and insulin-stimulated glucose uptake in human myotubes, coincident with increased glucose transporter 1 mRNA, and enhanced glucose transporter 1 abundance at the plasma membrane.
|
14 |
21309058
|
In isolated extensor digitorum longus muscle, FGF21 potentiated insulin-stimulated glucose transport, without altering phosphorylation of Akt or AMP-activated protein kinase.
|
15 |
18840786
|
FGF21 also reduced blood glucose, insulin, and lipid levels and reversed hepatic steatosis.
|
16 |
18460341
|
Via reduced release of fatty acids into the circulation, the anti-lipolytic effect could be a mechanism through which FGF21 promotes insulin sensitivity in man.
|
17 |
22046277
|
The changes in plasma FGF-21 levels (?FGF-21) were positively associated with the amelioration of insulin resistance shown by the changes in M value.
|
18 |
21973233
|
Fasting serum FGF-21 was found to correlate positively and significantly with age, waist-to-hip ratio, systolic blood pressure, fasting plasma glucose, glycosylated hemoglobin A1c, homeostasis model assessment (HOMA) of insulin resistance, and hsCRP, but negatively with HOMA of ?-cell insulin secretion.
|